Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Campulung – page 5

52 clinical trials in Campulung, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Campulung at a glance
52
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

52 trials in Campulung

Open in trial search

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Schizophrenia

Not recruiting

Study on the Effectiveness and Safety of SEP-363856 for Patients with Acute Schizophrenia Symptoms

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Ulotaront
  • Sponsor:Sumitomo Pharma Co. Ltd.

Study on the Safety and Efficacy of BIIB091 and Diroximel Fumarate for Patients with Relapsing Multiple Sclerosis

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:Corubrutinib
  • Sponsor:Biogen Idec Research Limited

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Campulung

What the registry says about research in the country

01 Multiple Sclerosis Research

Comprehensive investigation of novel treatments for relapsing multiple sclerosis (RMS), featuring comparative studies of innovative therapies like frexalimab and remibrutinib against established treatments.

  • Relapsing Forms Treatment
  • Long-term Safety Studies
  • Comparative Drug Efficacy

Multiple ongoing trials focusing on reducing relapse frequency and improving patient outcomes.

02 Progressive MS Studies

Dedicated research into primary progressive multiple sclerosis (PPMS), evaluating breakthrough treatments including BTK inhibitors and specialized therapies for disease progression.

  • Disease Progression Control
  • Disability Management
  • Advanced Imaging Analysis

Innovative approaches to addressing the unique challenges of progressive MS forms.

03 Neurological Conditions

Broader research portfolio including studies on migraine prevention and various nervous system conditions, with trials evaluating new therapeutic approaches for treatment-resistant cases.

  • Preventative Treatments
  • Novel Drug Development
  • Patient Response Assessment

Focus on developing solutions for patients who haven't responded to conventional treatments.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.